Your browser doesn't support javascript.
loading
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
Ratner, L; Rauch, D; Abel, H; Caruso, B; Noy, A; Barta, S K; Parekh, S; Ramos, J C; Ambinder, R; Phillips, A; Harding, J; Baydoun, H H; Cheng, X; Jacobson, S.
Afiliação
  • Ratner L; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Rauch D; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Abel H; Department of Genetics, Washington University School of Medicine, St Louis, MO, USA.
  • Caruso B; Viral Immunology Section, Neuroimmunology and Neurovirology Division, NINDS, NIH, Bethesda, MD, USA.
  • Noy A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Barta SK; Division of Hematology-Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Parekh S; Division of Hematology-Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Ramos JC; Division of Hematology-Oncology, Department of Medicine, University of Miami School of Medicine, Miami, FL, USA.
  • Ambinder R; Division of Hematologic Malignancies, Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Phillips A; Division of Hematology-Oncology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
  • Harding J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Baydoun HH; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Cheng X; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Jacobson S; Viral Immunology Section, Neuroimmunology and Neurovirology Division, NINDS, NIH, Bethesda, MD, USA.
Blood Cancer J ; 6: e408, 2016 Mar 25.
Article em En | MEDLINE | ID: mdl-27015285
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Leucemia-Linfoma de Células T do Adulto / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Leucemia-Linfoma de Células T do Adulto / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos